BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19724274)

  • 1. An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.
    Campbell HE; Taylor MA; Harris AL; Gray AM
    Br J Cancer; 2009 Oct; 101(7):1074-84. PubMed ID: 19724274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy validation of adjuvant! online in Taiwanese breast cancer patients--a 10-year analysis.
    Yao-Lung K; Dar-Ren C; Tsai-Wang C
    BMC Med Inform Decis Mak; 2012 Sep; 12():108. PubMed ID: 22985190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based validation of the prognostic model ADJUVANT! for early breast cancer.
    Olivotto IA; Bajdik CD; Ravdin PM; Speers CH; Coldman AJ; Norris BD; Davis GJ; Chia SK; Gelmon KA
    J Clin Oncol; 2005 Apr; 23(12):2716-25. PubMed ID: 15837986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
    Mook S; Schmidt MK; Rutgers EJ; van de Velde AO; Visser O; Rutgers SM; Armstrong N; van't Veer LJ; Ravdin PM
    Lancet Oncol; 2009 Nov; 10(11):1070-6. PubMed ID: 19801202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the adjuvant! Online model to Korean breast cancer patients: an assessment of prognostic accuracy and development of an alternative prognostic tool.
    Jung M; Choi EH; Nam CM; Rha SY; Jeung HC; Lee SH; Yang WI; Roh JK; Chung HC
    Ann Surg Oncol; 2013 Aug; 20(8):2615-24. PubMed ID: 23543197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK.
    Campbell HE; Gray AM; Harris AL; Briggs AH; Taylor MA
    Br J Cancer; 2010 Sep; 103(6):776-86. PubMed ID: 20823886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population-based validation of the prognostic model PREDICT for early breast cancer.
    Wishart GC; Bajdik CD; Azzato EM; Dicks E; Greenberg DC; Rashbass J; Caldas C; Pharoah PD
    Eur J Surg Oncol; 2011 May; 37(5):411-7. PubMed ID: 21371853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
    Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
    Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients.
    Bhoo-Pathy N; Yip CH; Hartman M; Saxena N; Taib NA; Ho GF; Looi LM; Bulgiba AM; van der Graaf Y; Verkooijen HM
    Eur J Cancer; 2012 May; 48(7):982-9. PubMed ID: 22366561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis in patients diagnosed with loco-regional failure of breast cancer: 34 years longitudinal data from the Stockholm-Gotland cancer registry.
    Falato C; Taylor SK; Szulkin R; Nordblom A; Eriksson L; Sofiadis A; Fredriksson I; Hartman J; Bergh J; Foukakis T
    Breast Cancer Res Treat; 2018 Dec; 172(3):703-712. PubMed ID: 30225620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database.
    Roberts MC; Miller DP; Shak S; Petkov VI
    Breast Cancer Res Treat; 2017 Jun; 163(2):303-310. PubMed ID: 28243896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underestimated survival predictions of the prognostic tools Adjuvant! Online and PREDICT in BRCA1-associated breast cancer patients.
    Plakhins G; Irmejs A; Gardovskis A; Subatniece S; Liepniece-Karele I; Purkalne G; Teibe U; Trofimovics G; Miklasevics E; Gardovskis J
    Fam Cancer; 2013 Dec; 12(4):683-9. PubMed ID: 23640109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment patterns and outcomes in older women with early breast cancer: a population-based cohort study in China.
    Liu X; Zheng D; Wu Y; Luo C; Fan Y; Zhong X; Zheng H
    BMC Cancer; 2021 Mar; 21(1):226. PubMed ID: 33673816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
    Chen HL; Zhou MQ; Tian W; Meng KX; He HF
    PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Breast Cancer Subtypes on Prognosis of Women with Operable Invasive Breast Cancer: A Population-based Study Using SEER Database.
    Hwang KT; Kim J; Jung J; Chang JH; Chai YJ; Oh SW; Oh S; Kim YA; Park SB; Hwang KR
    Clin Cancer Res; 2019 Mar; 25(6):1970-1979. PubMed ID: 30559169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database.
    Du ZL; Wang Y; Wang DY; Zhang L; Bian ZM; Deng Y; Xu CS; Lin DC; Xie L; Jia Y; Gao JD; Zhang BL
    Breast Cancer Res Treat; 2020 Sep; 183(2):429-438. PubMed ID: 32647940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.
    Elias AD; Ibrahim J; Richardson P; Avigan D; Joyce R; Reich E; McCauley M; Wheeler C; Frei E
    Biol Blood Marrow Transplant; 2002; 8(4):198-205. PubMed ID: 12017145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local-regional breast cancer recurrence: prognostic groups based on patterns of failure.
    Moran MS; Haffty BG
    Breast J; 2002; 8(2):81-7. PubMed ID: 11896752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.